Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CESMAC (Centre d'Etude des Substances Naturelles d'Origine Marine et Terrestre) is a specialized research and service platform based at the University of Nantes, France, that operates as a contract research organization (CRO) for the life sciences industry. The company provides advanced expertise in the extraction, isolation, and chemical characterization of natural products derived from marine and terrestrial sources. Its core services include metabolomics profiling, dereplication of complex mixtures, and the identification of bioactive small molecules for pharmaceutical, cosmetic, and nutraceutical applications. CESMAC leverages high-resolution mass spectrometry and NMR spectroscopy to accelerate drug discovery and ingredient development for its global partners. The platform is a key member of the Biogenouest network, supporting both academic research and industrial innovation in natural product chemistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CESMAC.